Analyst Ratings for PRA Health Sciences Inc. (PRAH)

Updated: 2017-07-26

An average rating of Buy has been given to PRA Health Sciences Inc. (NASDAQ:PRAH) by analysts covering the stock. Last month, PRAH received an average rating of Buy.

8 analysts declared PRAH a buy, 1 gave an overweight rating, 1 gave a hold rating, 0 issued an underweight rating, and 0 issued a sell rating. Today, there are 1 more analysts optimistic about the company future as compared with 90 days ago. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.

Many analysts weighed in on price targets for PRAH. The highest price target was 90, implying potential capital gains of 17.17 percent. The minimum price target given was 69, which equates to a potential downside of -10.17 percent. It is advisable to not rely only on price targets or ratings, as these can be biased for some stocks.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. That number becomes -0.68 percent if we expand the time horizon to include the past 3 months instead of just one. Meanwhile, fiscal year estimates have been revised upwards by 0.16 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 0.32 percent.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, which can be compared to the 0 analysts that decreased their estimates. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 0 analysts decreased their estimates.

Analysts estimate earnings of PRAH to grow at a rate of 79.29 percent. The PEG ratio of a stock is another value frequently studied by investors. Investors like to see smaller values for the PEG ratio, as that can indicate whether the high price level of a stock is warranted by high growth. People often look for the PEG ratio to be under 1, though it could be better to see where the ratio stands relative to peers in the industry. The PEG ratio of PRAH is 0.57.

In the last 52-weeks, PRAH has achieved a high of 79.98 and a low of 43.08. Today's price is 78.3 percent above the 52-week low, and 3.96 percent lower than its 52-week high. PRAH has a P/E ratio of 45.18. Investors typically compare the P/E ratio to a company's peers in the industry. The PRAH value stock report compares PRAH to some of its peers using value stock charts. The market cap of PRAH is $4.8 billion. PRAH will post this quarters earnings in days, on 0000-00-00.